Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jyotsna Mulgund

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
American Heart Journal|October 31, 2007
Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillationNancy M Allen LaPointe, Laura Governale, Jerry Watkins, et al.
Obstetrics and Gynecology|December 2, 2005
The FIBROID Registry: symptom and quality-of-life status 1 year after therapyJames B Spies, Evan R Myers, Robert Worthington-Kirsch, et al.
The American Journal of Cardiology|April 26, 2008
Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database)Nancy M Albert, Kimberly K Birtcher, Christopher P Cannon, et al.
Obstetrics and Gynecology|July 5, 2005
The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomesRobert Worthington-Kirsch, James B Spies, Evan R Myers, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Use of guidelines-recommended management and outcomes among women and men with low-level troponin elevation: insights from CRUSADESharif A Halim, Jyotsna Mulgund, Anita Y Chen, et al.
The American Journal of Medicine|August 7, 2007
Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarctionChadwick D Miller, Matthew T Roe, Jyotsna Mulgund, et al.
Diabetes Care|December 24, 2005
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromesGerard X Brogan, Eric D Peterson, Jyotsna Mulgund, et al.
The American Journal of Medicine|February 24, 2006
Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromesJin H Han, Abhinav Chandra, Jyotsna Mulgund, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|May 3, 2005
Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patternsJames W Hoekstra, Matthew T Roe, Eric D Peterson, et al.
Journal of the American College of Cardiology|July 18, 2006
Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgeryRajendra H Mehta, Matthew T Roe, Jyotsna Mulgund, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
American Heart Journal|October 31, 2007
Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillationNancy M Allen LaPointe, Laura Governale, Jerry Watkins, et al.
Obstetrics and Gynecology|December 2, 2005
The FIBROID Registry: symptom and quality-of-life status 1 year after therapyJames B Spies, Evan R Myers, Robert Worthington-Kirsch, et al.
The American Journal of Cardiology|April 26, 2008
Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database)Nancy M Albert, Kimberly K Birtcher, Christopher P Cannon, et al.
Obstetrics and Gynecology|July 5, 2005
The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomesRobert Worthington-Kirsch, James B Spies, Evan R Myers, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Use of guidelines-recommended management and outcomes among women and men with low-level troponin elevation: insights from CRUSADESharif A Halim, Jyotsna Mulgund, Anita Y Chen, et al.
The American Journal of Medicine|August 7, 2007
Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarctionChadwick D Miller, Matthew T Roe, Jyotsna Mulgund, et al.
Diabetes Care|December 24, 2005
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromesGerard X Brogan, Eric D Peterson, Jyotsna Mulgund, et al.
The American Journal of Medicine|February 24, 2006
Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromesJin H Han, Abhinav Chandra, Jyotsna Mulgund, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|May 3, 2005
Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patternsJames W Hoekstra, Matthew T Roe, Eric D Peterson, et al.
Journal of the American College of Cardiology|July 18, 2006
Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgeryRajendra H Mehta, Matthew T Roe, Jyotsna Mulgund, et al.
Pageof 3